Compare Stocks: ACH, BTMD, PRPO, and PIII

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACH Accendra Health	$0.20 -6.0%	$0.82	$0.19 ▼ $5.60	$15.23M	1.57	1.20 million shs	800,228 shs
BTMD biote	$1.07 -1.8%	$1.33	$1.00 ▼ $3.01	$38.45M	1.69	240,050 shs	65,694 shs
PIII P3 Health Partners	$4.29 -1.6%	$7.49	$1.52 ▼ $16.89	$30.99M	1.7	430,098 shs	10,951 shs
PRPO Precipio	$20.39 -1.1%	$25.43	$18.50 ▼ $33.63	$36.49M	1.3	59,542 shs	4,889 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACH Accendra Health	-9.40%	-23.03%	-76.08%	-93.44%	+20,519,900.00%
BTMD biote	+5.83%	-1.80%	-17.42%	-52.19%	-65.83%
PIII P3 Health Partners	+6.08%	+5.31%	-42.02%	-54.68%	-49.15%
PRPO Precipio	-3.01%	-8.56%	-21.52%	-12.96%	-3.22%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACH Accendra Health	$0.20 -6.0%	$0.82	$0.19 ▼ $5.60	$15.23M	1.57	1.20 million shs	800,228 shs
BTMD biote	$1.07 -1.8%	$1.33	$1.00 ▼ $3.01	$38.45M	1.69	240,050 shs	65,694 shs
PIII P3 Health Partners	$4.29 -1.6%	$7.49	$1.52 ▼ $16.89	$30.99M	1.7	430,098 shs	10,951 shs
PRPO Precipio	$20.39 -1.1%	$25.43	$18.50 ▼ $33.63	$36.49M	1.3	59,542 shs	4,889 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACH Accendra Health	-9.40%	-23.03%	-76.08%	-93.44%	+20,519,900.00%
BTMD biote	+5.83%	-1.80%	-17.42%	-52.19%	-65.83%
PIII P3 Health Partners	+6.08%	+5.31%	-42.02%	-54.68%	-49.15%
PRPO Precipio	-3.01%	-8.56%	-21.52%	-12.96%	-3.22%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACH Accendra Health	1.60	Reduce	$1.50	641.47% Upside
BTMD biote	2.50	Moderate Buy	$2.50	131.48% Upside
PIII P3 Health Partners	2.00	Hold	$17.00	319.75% Upside
PRPO Precipio	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest ACH, BTMD, PRPO, and PIII Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	PRPO Precipio	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/5/2026	ACH Accendra Health	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold ➝ Strong Sell
8/25/2026	PIII P3 Health Partners	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
8/13/2026	BTMD biote	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D+) ➝ Sell (D)
8/13/2026	ACH Accendra Health	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Neutral	$4.50 ➝ $1.50
8/11/2026	PIII P3 Health Partners	Lake Street Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$23.00
8/11/2026	ACH Accendra Health	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target	Outperform ➝ Neutral	$1.50
8/11/2026	ACH Accendra Health	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Outperform ➝ Neutral	$1.50
8/10/2026	ACH Accendra Health	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy ➝ Neutral	$4.50 ➝ $1.50
8/10/2026	BTMD biote	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Neutral	$2.00 ➝ $1.50
8/7/2026	BTMD biote	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$2.50 ➝ $2.00

(Data available from 10/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACH Accendra Health	$2.73B	0.01	$3.37 per share	0.06	($5.96) per share	-0.03
BTMD biote	$192.22M	0.20	$0.61 per share	1.77	($1.40) per share	-0.77
PIII P3 Health Partners	$1.46B	0.02	N/A	N/A	($21.55) per share	-0.19
PRPO Precipio	$24.05M	1.54	$0.77 per share	26.75	$8.31 per share	2.49

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACH Accendra Health	-$1.10B	-$3.91	N/A	2.25	N/A	-11.41%	-4.02%	0.70%	N/A
BTMD biote	$27.05M	$0.11	9.82	6.35	N/A	3.19%	-22.33%	12.10%	11/4/2026 (Estimated)
PIII P3 Health Partners	-$147.95M	-$33.00	N/A	N/A	N/A	-6.55%	N/A	-16.40%	11/12/2026 (Estimated)
PRPO Precipio	-$360K	-$0.64	N/A	N/A	N/A	-4.47%	-8.49%	-5.75%	11/16/2026 (Estimated)

Latest ACH, BTMD, PRPO, and PIII Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/16/2026	Q3 2026	PRPO Precipio	-$2.00	N/A	N/A	N/A	$1.68 million	N/A
11/12/2026	Q3 2026	PIII P3 Health Partners	-$3.9650	N/A	N/A	N/A	$384.95 million	N/A
11/4/2026	Q3 2026	BTMD biote	-$0.05	N/A	N/A	N/A	$44.01 million	N/A
8/14/2026	Q2 2026	PRPO Precipio	-$2.00	-$0.12	+$1.88	-$0.12	$1.68 million	$7.02 million
8/10/2026	Q2 2026	ACH Accendra Health	-$0.13	-$0.19	-$0.06	-$1.16	N/A	$613.23 million
8/10/2026	Q2 2026	PIII P3 Health Partners	-$1.89	-$0.63	+$1.26	-$0.63	$377.80 million	$386.38 million
8/5/2026	Q2 2026	BTMD biote	$0.0267	-$0.23	-$0.2567	-$0.23	$46.12 million	$44.23 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACH Accendra Health	N/A	N/A	N/A	N/A	N/A
BTMD biote	N/A	N/A	N/A	N/A	N/A
PIII P3 Health Partners	N/A	N/A	N/A	N/A	N/A
PRPO Precipio	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACH Accendra Health	N/A	0.41	0.30
BTMD biote	N/A	1.43	0.82
PIII P3 Health Partners	N/A	0.46	0.46
PRPO Precipio	0.06	1.77	1.56

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACH Accendra Health	N/A
BTMD biote	21.68%
PIII P3 Health Partners	7.75%
PRPO Precipio	10.45%

Insider Ownership

Company	Insider Ownership
ACH Accendra Health	2.29%
BTMD biote	32.40%
PIII P3 Health Partners	10.86%
PRPO Precipio	16.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACH Accendra Health	6,500	76.90 million	75.14 million	Optionable
BTMD biote	223	35.93 million	24.29 million	Not Optionable
PIII P3 Health Partners	320	7.26 million	6.47 million	Not Optionable
PRPO Precipio	71	1.79 million	1.49 million	No Data

ACH, BTMD, PRPO, and PIII Headlines

Recent News About These Companies

Precipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average - Here's Why

October 23 at 3:41 AM | americanbankingnews.com

Precipio reports USD 7.02 million Q2 revenue growth for stock investors

October 15, 2026 | ad-hoc-news.deA

Precipio (NASDAQ:PRPO) Shares Break Below Two Hundred Day Moving Average - What's Next?

October 15, 2026 | americanbankingnews.com

Precipio: Management Dreams Big, Institutions Have A Toe In

October 12, 2026 | seekingalpha.com

Precipio (NASDAQ:PRPO) Share Price Crosses Below 200 Day Moving Average – What’s Next?

October 7, 2026 | defenseworld.netD

PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?

September 22, 2026 | zacks.com

PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

August 24, 2026 | zacks.com

Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong

August 21, 2026 | zacks.com

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript

August 17, 2026 | seekingalpha.com

Precipio Announces Q2-2026 Financial Results

August 14, 2026 | globenewswire.com

Precipio Schedules Q2 2026 Shareholder Update Call

July 31, 2026 | tipranks.com

Precipio Announces Q2-2026 Shareholder Update Call

July 31, 2026 | globenewswire.com

Precipio Earnings Estimates, EPS & Revenue | NASDAQ:PRPO

July 21, 2026 | benzinga.com

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

July 16, 2026 | zacks.com

Precipio Inc.

June 28, 2026 | marketwatch.com

Top analyst reports for Caterpillar, Palo Alto & Toyota

June 26, 2026 | msn.com

Precipio Shareholders Back Board Nominees and Auditor

June 15, 2026 | tipranks.com

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

June 12, 2026 | globenewswire.com

Precipio to Present at the Planet MicroCap Las Vegas

June 11, 2026 | globenewswire.com

Precipio (PRPO) Q1 2026 Earnings Call Transcript

June 2, 2026 | fool.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ACH, BTMD, PRPO, and PIII Company Descriptions

Accendra Health NYSE:ACH

$0.20 -0.01 (-6.02%)

As of 02:05 PM Eastern

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

biote NASDAQ:BTMD

$1.07 -0.02 (-1.83%)

As of 02:09 PM Eastern

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

P3 Health Partners NASDAQ:PIII

$4.29 -0.07 (-1.63%)

As of 02:20 PM Eastern

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

Precipio NASDAQ:PRPO

$20.39 -0.23 (-1.09%)

As of 01:56 PM Eastern

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ACH, BTMD, PRPO, and PIII Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ACH, BTMD, PRPO, and PIII Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ACH, BTMD, PRPO, and PIII Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ACH, BTMD, PRPO, and PIII Company Descriptions

Accendra Health NYSE:ACH

biote NASDAQ:BTMD

P3 Health Partners NASDAQ:PIII

Precipio NASDAQ:PRPO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ACH, BTMD, PRPO, and PIII Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ACH, BTMD, PRPO, and PIII Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ACH, BTMD, PRPO, and PIII Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ACH, BTMD, PRPO, and PIII Company Descriptions

Accendra Health NYSE:ACH

biote NASDAQ:BTMD

P3 Health Partners NASDAQ:PIII

Precipio NASDAQ:PRPO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools